Silk Road Medical

Silk Road Medical is a United States medical-device company associated with transcarotid artery revascularization, or TCAR, a procedure for treating carotid artery disease. The company describes itself as the developer of TCAR and frames its work around improving patient outcomes through clinical innovation. Its products support the procedure with systems and devices intended for use by medical professionals. The product portfolio documented on the company’s site includes the ENROUTE Transcarotid Neuroprotection System, the ENROUTE Transcarotid Stent System, and the ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter. The company provides product instruction manuals and identifies catalog numbers and release dates for these devices. These materials establish the company’s focus on procedural medical technology; they do not provide enough information to characterize pricing, market share, or the full geographic reach of its business. Silk Road Medical is associated with Sunnyvale, California. It is now part of Boston Scientific, a medical-device company. Its public-facing identity remains closely tied to TCAR and the ENROUTE product family. The available evidence does not establish the company’s founding date, founder, current executives, or a detailed account of its operating structure, so those details are not stated here.

Silk Road Medical’s public identity is centered on transcarotid artery revascularization (TCAR). The company’s homepage identifies it as the developer of the procedure and presents its work as an effort to improve patient outcomes through clinical thinking. This establishes TCAR as the defining focus of the brand, but the supplied company materials do not give a founding date, explain the original development history, or identify the people who founded the business. The company’s product materials document a portfolio designed around TCAR. The ENROUTE family includes a Transcarotid Neuroprotection System, a Transcarotid Stent System, and an Enflate Transcarotid RX Balloon Dilatation Catheter. Instruction-manual listings identify product catalog information and release dates, including June 2025 for the neuroprotection system and balloon catheter and July 2025 for the stent system. These documents show the continued maintenance of product instructions, but do not by themselves establish the dates when the products were first launched or received regulatory authorization. Silk Road Medical is associated with Sunnyvale, United States, and was acquired by Boston Scientific in 2024. As part of that larger medical-device company, Silk Road Medical’s documented brand and product identity remains associated with TCAR and its ENROUTE devices. The available evidence does not support a fuller account of the company’s founding, earlier financing, clinical milestones, leadership history, or the operational details of its integration into Boston Scientific. Those points are therefore not expanded here.

• Acquired by Boston Scientific

• ENROUTE instruction-manual releases

• ENROUTE stent-system instruction manual

A medical-technology company centered on TCAR and the devices used to support the procedure.

• ENROUTE Transcarotid Neuroprotection System

  A neuroprotection system listed among the company’s TCAR product instructions.

• ENROUTE Transcarotid Stent System

  A stent system listed among the company’s TCAR product instructions.

• ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter

  A balloon dilatation catheter listed among the company’s TCAR product instructions.

• Acquisition by Boston ScientificOther

1. 1Silk Road Medical | Official Engineers Of The TCAR Proceduresilkroadmed.com
2. 2TCAR Product Instruction Manuals | Silk Road Medicalsilkroadmed.com
3. 3Silk Road Medical (United States)wikidata.org
4. 4Contact Boston Scientificbostonscientific.com